{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:34:40Z","timestamp":1790400880776,"version":"4.1.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/gme.0b013e3181788d88","type":"journal-article","created":{"date-parts":[[2008,7,2]],"date-time":"2008-07-02T03:06:34Z","timestamp":1214967994000},"page":"782-789","source":"Crossref","is-referenced-by-count":55,"title":["Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer"],"prefix":"10.1097","volume":"15","author":[{"given":"Victor G.","family":"Vogel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210227","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0091-7435(91)90009-S","article-title":"High-risk populations as targets for breast cancer prevention trials.","volume":"20","author":"Vogel","year":"1991","journal-title":"Prev Med"},{"key":"R2-4-20210227","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0039-6109(03)00030-6","article-title":"Management of the high-risk patient.","volume":"83","author":"Vogel","year":"2003","journal-title":"Surg Clin North Am"},{"key":"R5-4-20210227","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1158\/1055-9965.1558.13.10","article-title":"Etiology of hormone receptor-defined breast cancer: a systematic review of the literature.","volume":"13","author":"Althuis","year":"2004","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"Suppl 1","key":"R6-4-20210227","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2005.06.017","article-title":"Identification of risk factors for prevention and early diagnosis of asymptomatic post-menopausal women.","volume":"52","author":"Ferrer","year":"2005","journal-title":"Maturitas"},{"key":"R7-4-20210227","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/jnci\/djm228","article-title":"Absolute risk models for subtypes of breast cancer.","volume":"99","author":"Gail","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R9-4-20210227","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1015714305420","article-title":"Epidemiology of endocrine-related risk factors for breast cancer.","volume":"7","author":"Bernstein","year":"2002","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"R10-4-20210227","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/oxfordjournals.epirev.a036115","article-title":"Reproductive factors and breast cancer.","volume":"15","author":"Kelsey","year":"1993","journal-title":"Epidemiol Rev"},{"key":"R12-4-20210227","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/ijc.21404","article-title":"Epidemiology and the causes of breast cancer.","volume":"118","author":"MacMahon","year":"2006","journal-title":"Int J Cancer"},{"key":"R13-4-20210227","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-143-6-200509200-00009","article-title":"Premalignant and in situ breast disease: biology and clinical implications.","volume":"143","author":"Arpino","year":"2005","journal-title":"Ann Intern Med"},{"key":"R14-4-20210227","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/ERC-06-0045","article-title":"Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model.","volume":"14","author":"Santen","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"R15-4-20210227","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1056\/NEJMra035692","article-title":"Benign breast disorders.","volume":"353","author":"Santen","year":"2005","journal-title":"N Engl J Med"},{"key":"R16-4-20210227","first-page":"297","article-title":"Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.","volume":"6","author":"Marshall","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R17-4-20210227","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S1072-7515(02)01189-4","article-title":"Evaluation and management of the woman with an abnormal ductal lavage.","volume":"194","author":"Morrow","year":"2002","journal-title":"J Am Coll Surg"},{"key":"R18-4-20210227","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/dc.20004","article-title":"Atypia in the assessment of breast cancer risk: implications for management.","volume":"30","author":"Vogel","year":"2004","journal-title":"Diagn Cytopathol"},{"key":"R19-4-20210227","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer.","volume":"353","author":"Hartmann","year":"2005","journal-title":"N Engl J Med"},{"key":"R20-4-20210227","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/jnci\/92.15.1217","article-title":"Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model.","volume":"92","author":"Fabian","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R21-4-20210227","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.ejca.2006.03.019","article-title":"The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?","volume":"42","author":"Lakhani","year":"2006","journal-title":"Eur J Cancer"},{"key":"R22-4-20210227","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1634\/theoncologist.9-1-13","article-title":"Recognition and management of hereditary breast cancer syndromes.","volume":"9","author":"Thull","year":"2004","journal-title":"Oncologist"},{"key":"R23-4-20210227","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10689-004-9550-2","article-title":"Hereditary breast cancer in Jews.","volume":"3","author":"Rubinstein","year":"2004","journal-title":"Fam Cancer"},{"key":"R24-4-20210227","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1038\/sj.onc.1209879","article-title":"Models of genetic susceptibility to breast cancer.","volume":"25","author":"Antoniou","year":"2006","journal-title":"Oncogene"},{"key":"R25-4-20210227","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1200\/JCO.2005.04.0345","article-title":"Ductal carcinoma in situ in BRCA mutation carriers.","volume":"25","author":"Hwang","year":"2007","journal-title":"J Clin Oncol"},{"key":"R26-4-20210227","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jama.293.8.964","article-title":"Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ.","volume":"293","author":"Claus","year":"2005","journal-title":"JAMA"},{"key":"R27-4-20210227","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1258\/136218006779160436","article-title":"Mammographic density: a hormonally responsive risk factor for breast cancer.","volume":"12","author":"Boyd","year":"2006","journal-title":"J Br Menopause Soc"},{"key":"R28-4-20210227","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJMoa062790","article-title":"Mammographic density and the risk and detection of breast cancer.","volume":"356","author":"Boyd","year":"2007","journal-title":"N Engl J Med"},{"key":"R29-4-20210227","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10549-005-5152-4","article-title":"Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population.","volume":"94","author":"Tice","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"R30-4-20210227","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/jnci\/djm062","article-title":"Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.","volume":"99","author":"Tamimi","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R31-4-20210227","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/jnci\/djk066","article-title":"Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.","volume":"99","author":"Kerlikowske","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R32-4-20210227","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jnci\/djj332","article-title":"Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density.","volume":"98","author":"Chen","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R33-4-20210227","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1200\/JCO.2001.19.12.3111","article-title":"Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants.","volume":"19","author":"Lippman","year":"2001","journal-title":"J Clin Oncol"},{"key":"R34-4-20210227","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/jama.287.2.216","article-title":"Serum estradiol level and risk of breast cancer during treatment with raloxifene.","volume":"287","author":"Cummings","year":"2002","journal-title":"JAMA"},{"key":"R36-4-20210227","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1200\/JCO.2005.03.7432","article-title":"Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk?","volume":"24","author":"Eliassen","year":"2006","journal-title":"J Clin Oncol"},{"key":"R37-4-20210227","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/94.8.606","article-title":"Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.","volume":"94","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R38-4-20210227","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jnci\/djj011","article-title":"Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).","volume":"98","author":"Beattie","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R39-4-20210227","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1200\/JCO.2005.05.4122","article-title":"Have we found the ultimate risk factor for breast cancer?","volume":"24","author":"Vogel","year":"2006","journal-title":"J Clin Oncol"},{"key":"R40-4-20210227","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/jama.1996.03540170048031","article-title":"Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group.","volume":"276","author":"Cauley","year":"1996","journal-title":"JAMA"},{"key":"R41-4-20210227","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF02951423","article-title":"Diet and breast cancer.","volume":"9","author":"Linos","year":"2007","journal-title":"Curr Oncol Rep"},{"key":"R42-4-20210227","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00003677-200410000-00010","article-title":"Physical activity and breast cancer risk: the effect of menopausal status.","volume":"32","author":"Friedenreich","year":"2004","journal-title":"Exerc Sport Sci Rev"},{"key":"R43-4-20210227","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0960-9776(03)00145-0","article-title":"Nutrition and breast cancer.","volume":"12","author":"Key","year":"2003","journal-title":"Breast"},{"key":"R44-4-20210227","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1753-4887.2006.tb00178.x","article-title":"Does a high folate intake increase the risk of breast cancer?","volume":"64","author":"Kim","year":"2006","journal-title":"Nutr Rev"},{"key":"R45-4-20210227","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.295.6.629","article-title":"Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.","volume":"295","author":"Prentice","year":"2006","journal-title":"JAMA"},{"key":"R46-4-20210227","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ajcn\/80.1.5","article-title":"Moorman, Patricia G, Terry, Paul D. Consumption of dairy products and the risk of breast cancer: a review of the literature.","volume":"80","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"R47-4-20210227","first-page":"113","article-title":"Estrogens and organochlorine xenoestrogens and breast cancer risk.","volume":"16","author":"Starek","year":"2003","journal-title":"Int J Occup Med Environ Health"},{"key":"R48-4-20210227","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00008469-200312000-00010","article-title":"Environmental exposure to polychlorinated biphenyls (PCBs) and breast cancer: a systematic review of the epidemiological evidence.","volume":"12","author":"Negri","year":"2003","journal-title":"Eur J Cancer Prev"},{"key":"R49-4-20210227","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"R50-4-20210227","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","article-title":"Validation studies for models projecting the risk of invasive and total breast cancer incidence.","volume":"91","author":"Costantino","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R51-4-20210227","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/jnci\/86.8.620","article-title":"Validation of a breast cancer risk assessment model in women with a positive family history.","volume":"86","author":"Bondy","year":"1984","journal-title":"J Natl Cancer Inst"},{"key":"R52-4-20210227","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jnci\/86.8.600","article-title":"Validation of the Gail et al. model for predicting individual breast cancer risk.","volume":"86","author":"Spiegelman","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"R53-4-20210227","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","article-title":"Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.","volume":"93","author":"Rockhill","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R54-4-20210227","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors.","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"key":"R55-4-20210227","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/jnci\/djm223","article-title":"Projecting individualized absolute invasive breast cancer risk in African American women.","volume":"99","author":"Gail","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R56-4-20210227","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial.","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"R57-4-20210227","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/jnci\/dji064","article-title":"Ethnicity and breast cancer: factors influencing differences in incidence and outcome.","volume":"7","author":"Chlebowski","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R58-4-20210227","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jnci\/djj365","article-title":"Assessing breast cancer risk: evolution of the Gail model.","volume":"98","author":"Bondy","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R59-4-20210227","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/djj331","article-title":"Prospective breast cancer risk prediction model for women undergoing screening mammography.","volume":"98","author":"Barlow","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R60-4-20210227","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/jnci\/djm224","article-title":"Predicting risk of breast cancer in postmenopausal women by hormone receptor status.","volume":"99","author":"Chlebowski","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R61-4-20210227","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/gme.0b013e318178863e","article-title":"Chemoprevention in postmenopausal women.","volume":"15","author":"Rastogi","year":"2008","journal-title":"Menopause"},{"key":"R62-4-20210227","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/jnci\/95.7.526","article-title":"Estimates of the number of U.S. women who could benefit from tamoxifen for breast cancer chemoprevention.","volume":"95","author":"Freedman","year":"2003","journal-title":"J Natl Cancer Inst"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/gme.0b013e3181788d88","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:11:51Z","timestamp":1786036311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-200815041-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3181788d88","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}